Expert Review of Anti-Infective Therapy

Article	Citations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	95
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	85
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	66
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	65
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	65
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	62
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	54
Visceral leishmaniasis elimination in India: progress and the road ahead	50
Neonatal ocular prophylaxis in the United States: is it still necessary?	43
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	39
Challenges in preserving antibiotic effectiveness: time for a novel approach	38
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	35
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	35
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	34
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	32
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	29
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	29
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	28
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	26
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	25
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	24
Treatment of vaginitis caused by non-albicans Candida species	24
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	22

Reemergence of monkeypox: prevention and management	22
Identifying predictors of treatment failure with community-acquired pneumonia: an update	20
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	20
Phage- and enzybiotic-coated urinary catheters to prevent recurrent multidrug-resistant bacterial infections	19
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?	19
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	19
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline	19
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review	17
Advances and controversies in the diagnosis and management of neurocysticercosis: a clinical perspective	17
Diagnostic and clinical management of Candida auris infections in immunocompromised patients	17
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges	16
Infliximab as a potential treatment for COVID-19	16
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	16
Real-world effectiveness and tolerability of post solid organ transplant patients with CMV switching from valganciclovir treatment to maribavir: analysis using lab-linked claims data in the United Sta	15
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19	15
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance	15
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases	15
Theranostic nanomaterials for scalp and hair fungal infections: advancing diagnosis and treatment amidst challenges	15
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases	15
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures	15
Statement of Retraction	14
Correction	14
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury	14
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential	14
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India	14
Diagnostic and management strategies for chronic hepatitis E infection	14
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections	13
Diagnosing fungal infections in clinical practice: a narrative review	13
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	13
The serological dilemma: rethinking syphilis treatment evaluation	13
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches	13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana	12
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	11
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	11
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	11
The evolving debate around screening for Chlamydia trachomatis	11
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae	11
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review	11
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?	11
Monoclonal antibodies for the treatment of COVID-19 infection in children	11
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat	11
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	11
Challenges associated with pertussis detection, monitoring, and vaccination in adults	11
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	11
How can we tackle the overuse of antibiotics in low- and middle-income countries?	10
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	10
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea	10
How do we best manage Clostridioides difficle infections in the elderly?	10
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition	10
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	10

Now that griseofulvin is not available, what to do with tinea capitis treatments?	10
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	10
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	10
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study	10
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	9
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	9
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	9
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	9
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	9
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	9
New insights into the treatment of acute otitis media	9
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	9
Gram-positive infections in special populations. Expert view on the role of dalbavancin	9
Tocilizumab for the treatment of COVID-19	9
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	9
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	9
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients	8
Women trailblazers shaping the global future of antimicrobial stewardship and antimicrobial resistance	8
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	8
Strengths and caveats of identifying resistance genes from whole genome sequencing data	8
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study	8
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo	8
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	8
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	8
Ivermectin: a pathway out of the pandemic or another dead end?	8
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan	8
Past, present, and future perspectives on aztreonam and avibactam	8
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options	8
Artificial intelligence and prescription of antibiotic therapy: present and future	8
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	8
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials	8
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis	8
Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection	8
An update on newer antifungals	8
Introduction and spread of NDM-producing Enterobacterales and Acinetobacter baumannii into Middle Eastern countries: a molecular-based hypothesis	7
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak	7
The prevalence of antimicrobial drug resistance of non-typhoidal Salmonella in human infections in sub-Saharan Africa: a systematic review and meta-analysis	7
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critical	7
A systems thinking approach for antimicrobial stewardship in primary care	7
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects	7
The war against bacteria, from the past to present and beyond	7
High frequency and molecular characterization of ESBL-producing Enterobacteriaceae isolated from wound infections in North Lebanon	7
Host defense mechanisms against Candida auris	7
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV	7
Global importance of new treatment strategies to efforts to control hepatitis B virus	7
Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection	7
Containment strategies for COVID-19 in India: lessons from the second wave	7
Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review	6
Non-cancerous complications in HTLV-1 carriers	6
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose	6
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	6
Can probiotics replace antibiotics? Not yet, says the evidence	6
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	6
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis	6
Brucellosis control methods with an emphasis on vaccination: a systematic review	6
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?	6
Brincidofovir in the Era of Mpox	6
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	6
Mitigation of insufficient hospital workforce and personal protective equipment in the anti-COVID-19 campaign in mainland China	6
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	6
HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity	6
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis	6
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow	6
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	6
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	6
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	5
Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU	5
Gram-negative blood stream infections: prospects and challenges of rapid antimicrobial susceptibility testing	5
Langya henipavirus outbreak	5
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	5
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	5
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?	5
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	5
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges	5
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials	5
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	5
Candida auris biofilm: a review on model to mechanism conservation	5
A plain language summary of the safety and effectiveness of isavuconazole for the treatment of serious fungal disease in children with a weakened immune system	5
Phage therapy in pediatrics: the way forward for difficult-to-treat infections?	5

The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	5
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world	5
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	5
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	5
Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis	5
From guesswork to guidelines: advancing diagnostic stewardship in immunocompromised hosts	5
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	5
Omadacycline in treating community-based infections: a review and expert perspective	5
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	5
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	5
How do we change our approach to COVID with the changing face of disease?	5
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	5
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	5
The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis	5
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis	5
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	5
Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis	4
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori	4
False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews	4
Artificial intelligence and its application in clinical microbiology	4
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials	4
Immunocompromised patients and COVID-19: how do we protect those most at risk?	4
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis	4
Continuous care engagement in clinical practice: perspectives on selected current strategies for people with HIV in the United States	4
Personalized care approaches to hepatitis C therapy: recent advances and future directions	4
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence	4
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae	4
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution	4
Letter to the Editor: the earliest observation of bla NDM was in Israel	4
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials	4
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis	4
Nirmatrelvir/ritonavir: real world drug–drug interaction management experience	4
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants	4
New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway	4
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review	4
Antibiotic resistance in low- and middle-income countries: current practices and its global implications	4
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	4
Letter to the editor: “real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients”	4
Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis	4
Assessment of rationality of available fixed dose combinations of antibiotics in India	4
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	4
Secnidazole: a treatment for trichomoniasis in adolescents and adults	4
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	3
Doxycycline post-exposure prophylaxis as prevention of STIs – the golden bullet?	3
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	3
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	3
Statement of Retraction: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	3
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	3
Biosimilars as antivirals: opportunities and challenges	3
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	3
Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice	3
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	3
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis	3
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities	3
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences	3
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae	3
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?	3
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	3
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy	3
Antimicrobial management of complex biofilms in diabetic foot ulcers: a microbiological perspective	3
Concerns with current Drug Laws regarding the purchasing antibiotics without a prescription in Pakistan; ways forward to assist the national action plan	3
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	3
Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?	3
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread	3
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance	3
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications	3
Penile microbiomes have important implications for HIV susceptibility and broader reproductive health	3
From Data to Decisions: Leveraging Large, Real-World Databases to Guide Clinical Practice in C. difficile Infections	3
The antifungal pipeline for invasive fungal diseases: what does the future hold?	3
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	3
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	3
Managing sepsis in the era of precision medicine: challenges and opportunities	3
Therapeutic strategies to address monkeypox	3
Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatment	3
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review	3